MAGL-IN-8
MAGL-IN-8 (compound 13) is a reversible monoacylglycerol lipase (MAGL) inhibitor, with an IC50 of 2.5 ± 0.4 nM for hMAGL[1].
Product Specifications
CAS Number
3017151-71-9
UNSPSC
12352005
Target
MAGL
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/magl-in-8.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=CC(O)=C1)N2CCC(CC3=CC=CC(SC4=NC=CC(C(F)(F)F)=C4)=C3)CC2
Molecular Formula
C25H23F3N2O2S
Molecular Weight
472.52
References & Citations
[1]Granchi C, et al. Design, synthesis and biological evaluation of second-generation benzoylpiperidine derivatives as reversible monoacylglycerol lipase (MAGL) inhibitors. Eur J Med Chem. 2021 Jan 1;209:112857.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB1820-100 1x 100 µL
Ep-CAM / CD326 (Epithelial Marker) (rVU-1D9), 0.2mg/mL
Sign In for Pricing
View Details 
